Acid-suppressive effects of generic omeprazole: Comparison of three brands of generic omeprazole with original omeprazole
Digestive and Liver Disease Volume 38 Issue 8
Page 554-559
published_at 2006-08
アクセス数 : 630 件
ダウンロード数 : 336 件
今月のアクセス数 : 1 件
今月のダウンロード数 : 3 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00015022
File | |
Title ( eng ) |
Acid-suppressive effects of generic omeprazole: Comparison of three brands of generic omeprazole with original omeprazole
|
Creator |
Shimatani Tomohiko
Inoue M.
Kuroiwa T.
Xu J.
Mieno H.
Tazuma S.
|
Source Title |
Digestive and Liver Disease
|
Volume | 38 |
Issue | 8 |
Start Page | 554 |
End Page | 559 |
Abstract |
Background: Generic omeprazole contains the same active ingredient as original omeprazole and require verification of the bioequivalence with original omeprazole. However, very few clinical studies have been reported. Aims: A prospective, randomised, open-label, crossover study to compare acid-suppressive effect of generic omeprazole with that of original omeprazole. Subjects: Seven healthy Helicobacter pylori-negative subjects of CYP2C19 extensive metaboliser. Methods: Intragastric pH was measured for 24 h without medications (placebo) and on day 7 of repeated administration of 10 mg once daily after breakfast of original omeprazole, Omeprazon, or three brands of generic omeprazole, Omeprazole-Towa, Ovulanze or Omerap. Results: Median values of intragastric pH and percentages of time with pH > 4 for 24 h were significantly higher with administration of any omeprazole formulation compared with placebo (P < 0.05, Wilcoxon signed-rank test). Whereas, during the night-time period (20:00-08:00 h), percentages of time with pH > 4 with Omeprazole-Towa and Omerap were not significantly higher than placebo. Compared with Omeprazon, these two parameters for 24 h showed significantly greater inter-subject variations with Omeprazole-Towa (P < 0.05 and P < 0.01, F-test) and Ovulanze (P < 0.05). Conclusions: Acid-suppressive effects of some brands of generic omeprazole are not the same as original omeprazole. These differences might be reflected in clinical outcomes.
|
Keywords |
Generic product
Intragastric pH
Omeprazole
|
NDC |
Medical sciences [ 490 ]
|
Language |
eng
|
Resource Type | journal article |
Publisher |
Elsevier
|
Date of Issued | 2006-08 |
Publish Type | Author’s Original |
Access Rights | open access |
Source Identifier |
[ISSN] 1590-8658
[DOI] 10.1016/j.dld.2006.01.032
[PMID] 16524789
[NCID] AA11610665
[DOI] http://dx.doi.org/10.1016/j.dld.2006.01.032
isVersionOf
|